India plans 50% increase in oxygen production before third Covid wave

As of Monday, India's total Covid-19 cases had reached 33.03 million, with the death toll at 440,752, according to health ministry data

covid
Representative image
Reuters Bengaluru
2 min read Last Updated : Sep 06 2021 | 6:50 PM IST
India aims to ramp up its medical oxygen production capacity to 15,000 tonnes per day before a potential third wave of coronavirus infections that is expected to hit the country as soon as mid-September, an industry executive said.

The target implies a 50% jump from the maximum output of almost 10,000 tonnes reached earlier this year during the peak of the second COVID-19 wave, when hospitals ran short of the gas and relatives of patients had to search out oxygen cylinders.

Linde India supplied nearly one-third of the total oxygen demand during the peak.

Moloy Banerjee, head of Linde South Asia, said that while the government is targeting 15,000 tonnes of medical oxygen per day, Linde and other manufacturers were hoping to hit production of at least 13,500 tonnes per day ahead of the third wave.

As of Monday, India's total COVID-19 cases had reached 33.03 million, with the death toll at 440,752, according to health ministry data.

While demand for medical oxygen in India has considerably reduced since the peak, reaching near pre-COVID levels, gas companies along with the government are gearing up for a scenario where the third wave could be worse than the previous one.

The New Delhi government said last month it will increase oxygen production by setting up new manufacturing units or expanding the production capacity of existing units for uninterrupted oxygen supply during a health crisis.

Shares of Linde India rose to record levels in the days following the Delhi government's notification and have more than doubled for the year as of Monday's closing price.

"There have been discussions with the Delhi government since the second wave of COVID-19. We are still reviewing the policy and trying to see if it is workable for Linde," Banerjee added.

The company has not entered any formal agreement with the government.

Linde has also been in touch with the governments of Andhra Pradesh and Madhya Pradesh states to support setting up of additional oxygen storage capacities and manufacturing units.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story